Free Trial

Evolent Health (EVH) Competitors

Evolent Health logo
$4.82 -0.08 (-1.53%)
As of 01:17 PM Eastern
This is a fair market value price provided by Massive. Learn more.

EVH vs. SDGR, CERT, TDOC, GDRX, and HSTM

Should you buy Evolent Health stock or one of its competitors? Evolent Health's main competitors and comparable companies include Schrodinger (SDGR), Certara (CERT), Teladoc Health (TDOC), GoodRx (GDRX), and HealthStream (HSTM). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare technology" industry.

How does Evolent Health compare to Schrodinger?

Evolent Health (NYSE:EVH) and Schrodinger (NASDAQ:SDGR) are both healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their media sentiment, dividends, institutional ownership, earnings, valuation, profitability, analyst recommendations and risk.

In the previous week, Schrodinger had 12 more articles in the media than Evolent Health. MarketBeat recorded 13 mentions for Schrodinger and 1 mentions for Evolent Health. Schrodinger's average media sentiment score of 0.64 beat Evolent Health's score of 0.00 indicating that Schrodinger is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Evolent Health
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Schrodinger
6 Very Positive mention(s)
1 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

79.1% of Schrodinger shares are held by institutional investors. 1.5% of Evolent Health shares are held by insiders. Comparatively, 10.1% of Schrodinger shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Evolent Health has a net margin of -21.67% compared to Schrodinger's net margin of -22.02%. Evolent Health's return on equity of -6.07% beat Schrodinger's return on equity.

Company Net Margins Return on Equity Return on Assets
Evolent Health-21.67% -6.07% -1.23%
Schrodinger -22.02%-18.12%-9.07%

Evolent Health has a beta of 1.03, meaning that its share price is 3% more volatile than the broader market. Comparatively, Schrodinger has a beta of 1.69, meaning that its share price is 69% more volatile than the broader market.

Schrodinger has lower revenue, but higher earnings than Evolent Health. Schrodinger is trading at a lower price-to-earnings ratio than Evolent Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Evolent Health$1.88B0.29-$534.51M-$4.54N/A
Schrodinger$269.20M8.10-$103.26M-$0.79N/A

Evolent Health presently has a consensus target price of $6.04, indicating a potential upside of 23.61%. Schrodinger has a consensus target price of $26.67, indicating a potential downside of 9.70%. Given Evolent Health's stronger consensus rating and higher probable upside, research analysts clearly believe Evolent Health is more favorable than Schrodinger.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Evolent Health
1 Sell rating(s)
3 Hold rating(s)
10 Buy rating(s)
0 Strong Buy rating(s)
2.64
Schrodinger
1 Sell rating(s)
3 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.38

Summary

Evolent Health and Schrodinger tied by winning 8 of the 16 factors compared between the two stocks.

How does Evolent Health compare to Certara?

Certara (NASDAQ:CERT) and Evolent Health (NYSE:EVH) are both small-cap healthcare companies, but which is the better business? We will compare the two businesses based on the strength of their risk, profitability, earnings, dividends, institutional ownership, media sentiment, analyst recommendations and valuation.

Certara has a beta of 1.3, suggesting that its stock price is 30% more volatile than the broader market. Comparatively, Evolent Health has a beta of 1.03, suggesting that its stock price is 3% more volatile than the broader market.

Certara has higher earnings, but lower revenue than Evolent Health. Certara is trading at a lower price-to-earnings ratio than Evolent Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Certara$425.76M4.15-$1.60M-$0.42N/A
Evolent Health$1.88B0.29-$534.51M-$4.54N/A

In the previous week, Certara had 2 more articles in the media than Evolent Health. MarketBeat recorded 3 mentions for Certara and 1 mentions for Evolent Health. Certara's average media sentiment score of 0.96 beat Evolent Health's score of 0.00 indicating that Certara is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Certara
1 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Evolent Health
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

74.0% of Certara shares are owned by institutional investors. 1.1% of Certara shares are owned by insiders. Comparatively, 1.5% of Evolent Health shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Certara has a net margin of -16.14% compared to Evolent Health's net margin of -21.67%. Certara's return on equity of 3.36% beat Evolent Health's return on equity.

Company Net Margins Return on Equity Return on Assets
Certara-16.14% 3.36% 2.31%
Evolent Health -21.67%-6.07%-1.23%

Certara currently has a consensus target price of $9.92, indicating a potential downside of 14.29%. Evolent Health has a consensus target price of $6.04, indicating a potential upside of 23.61%. Given Evolent Health's stronger consensus rating and higher probable upside, analysts clearly believe Evolent Health is more favorable than Certara.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Certara
1 Sell rating(s)
7 Hold rating(s)
4 Buy rating(s)
1 Strong Buy rating(s)
2.38
Evolent Health
1 Sell rating(s)
3 Hold rating(s)
10 Buy rating(s)
0 Strong Buy rating(s)
2.64

Summary

Certara beats Evolent Health on 11 of the 17 factors compared between the two stocks.

How does Evolent Health compare to Teladoc Health?

Teladoc Health (NYSE:TDOC) and Evolent Health (NYSE:EVH) are both small-cap healthcare companies, but which is the better business? We will compare the two businesses based on the strength of their valuation, risk, analyst recommendations, earnings, dividends, institutional ownership, media sentiment and profitability.

Teladoc Health has a net margin of -6.27% compared to Evolent Health's net margin of -21.67%. Evolent Health's return on equity of -6.07% beat Teladoc Health's return on equity.

Company Net Margins Return on Equity Return on Assets
Teladoc Health-6.27% -11.63% -5.53%
Evolent Health -21.67%-6.07%-1.23%

Teladoc Health has a beta of 2, indicating that its stock price is 100% more volatile than the broader market. Comparatively, Evolent Health has a beta of 1.03, indicating that its stock price is 3% more volatile than the broader market.

76.8% of Teladoc Health shares are held by institutional investors. 0.7% of Teladoc Health shares are held by insiders. Comparatively, 1.5% of Evolent Health shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Teladoc Health has higher revenue and earnings than Evolent Health. Teladoc Health is trading at a lower price-to-earnings ratio than Evolent Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Teladoc Health$2.47B0.65-$200.32M-$0.86N/A
Evolent Health$1.88B0.29-$534.51M-$4.54N/A

In the previous week, Teladoc Health had 9 more articles in the media than Evolent Health. MarketBeat recorded 10 mentions for Teladoc Health and 1 mentions for Evolent Health. Teladoc Health's average media sentiment score of 0.65 beat Evolent Health's score of 0.00 indicating that Teladoc Health is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Teladoc Health
5 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Evolent Health
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Teladoc Health presently has a consensus price target of $8.53, suggesting a potential downside of 3.09%. Evolent Health has a consensus price target of $6.04, suggesting a potential upside of 23.61%. Given Evolent Health's stronger consensus rating and higher possible upside, analysts plainly believe Evolent Health is more favorable than Teladoc Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Teladoc Health
2 Sell rating(s)
11 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.17
Evolent Health
1 Sell rating(s)
3 Hold rating(s)
10 Buy rating(s)
0 Strong Buy rating(s)
2.64

Summary

Teladoc Health beats Evolent Health on 9 of the 16 factors compared between the two stocks.

How does Evolent Health compare to GoodRx?

GoodRx (NASDAQ:GDRX) and Evolent Health (NYSE:EVH) are both small-cap healthcare companies, but which is the better business? We will contrast the two companies based on the strength of their analyst recommendations, risk, dividends, profitability, earnings, media sentiment, valuation and institutional ownership.

GoodRx has a net margin of 2.07% compared to Evolent Health's net margin of -21.67%. GoodRx's return on equity of 7.22% beat Evolent Health's return on equity.

Company Net Margins Return on Equity Return on Assets
GoodRx2.07% 7.22% 2.53%
Evolent Health -21.67%-6.07%-1.23%

GoodRx has higher earnings, but lower revenue than Evolent Health. Evolent Health is trading at a lower price-to-earnings ratio than GoodRx, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
GoodRx$785.23M1.55$30.44M$0.0489.00
Evolent Health$1.88B0.29-$534.51M-$4.54N/A

63.8% of GoodRx shares are owned by institutional investors. 5.9% of GoodRx shares are owned by company insiders. Comparatively, 1.5% of Evolent Health shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

GoodRx presently has a consensus target price of $4.15, suggesting a potential upside of 16.57%. Evolent Health has a consensus target price of $6.04, suggesting a potential upside of 23.61%. Given Evolent Health's stronger consensus rating and higher probable upside, analysts plainly believe Evolent Health is more favorable than GoodRx.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
GoodRx
3 Sell rating(s)
6 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.08
Evolent Health
1 Sell rating(s)
3 Hold rating(s)
10 Buy rating(s)
0 Strong Buy rating(s)
2.64

In the previous week, GoodRx had 5 more articles in the media than Evolent Health. MarketBeat recorded 6 mentions for GoodRx and 1 mentions for Evolent Health. GoodRx's average media sentiment score of 0.46 beat Evolent Health's score of 0.00 indicating that GoodRx is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
GoodRx
0 Very Positive mention(s)
1 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Evolent Health
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

GoodRx has a beta of 1.66, meaning that its stock price is 66% more volatile than the broader market. Comparatively, Evolent Health has a beta of 1.03, meaning that its stock price is 3% more volatile than the broader market.

Summary

GoodRx beats Evolent Health on 12 of the 16 factors compared between the two stocks.

How does Evolent Health compare to HealthStream?

Evolent Health (NYSE:EVH) and HealthStream (NASDAQ:HSTM) are both small-cap healthcare companies, but which is the better business? We will contrast the two companies based on the strength of their earnings, dividends, institutional ownership, profitability, valuation, analyst recommendations, media sentiment and risk.

Evolent Health currently has a consensus price target of $6.04, suggesting a potential upside of 23.61%. HealthStream has a consensus price target of $36.00, suggesting a potential upside of 28.71%. Given HealthStream's higher probable upside, analysts clearly believe HealthStream is more favorable than Evolent Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Evolent Health
1 Sell rating(s)
3 Hold rating(s)
10 Buy rating(s)
0 Strong Buy rating(s)
2.64
HealthStream
0 Sell rating(s)
4 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.20

69.6% of HealthStream shares are held by institutional investors. 1.5% of Evolent Health shares are held by company insiders. Comparatively, 20.4% of HealthStream shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

HealthStream has a net margin of 6.25% compared to Evolent Health's net margin of -21.67%. HealthStream's return on equity of 6.37% beat Evolent Health's return on equity.

Company Net Margins Return on Equity Return on Assets
Evolent Health-21.67% -6.07% -1.23%
HealthStream 6.25%6.37%4.37%

In the previous week, HealthStream had 1 more articles in the media than Evolent Health. MarketBeat recorded 2 mentions for HealthStream and 1 mentions for Evolent Health. HealthStream's average media sentiment score of 0.37 beat Evolent Health's score of 0.00 indicating that HealthStream is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Evolent Health
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
HealthStream
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

HealthStream has lower revenue, but higher earnings than Evolent Health. Evolent Health is trading at a lower price-to-earnings ratio than HealthStream, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Evolent Health$1.88B0.29-$534.51M-$4.54N/A
HealthStream$304.06M2.82$18.34M$0.7039.96

Evolent Health has a beta of 1.03, meaning that its share price is 3% more volatile than the broader market. Comparatively, HealthStream has a beta of 0.45, meaning that its share price is 55% less volatile than the broader market.

Summary

HealthStream beats Evolent Health on 12 of the 16 factors compared between the two stocks.

Get Evolent Health News Delivered to You Automatically

Sign up to receive the latest news and ratings for EVH and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding EVH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

EVH vs. The Competition

MetricEvolent HealthHealthcare Technology IndustryHealthcare SectorNYSE Exchange
Market Cap$545.74M$1.98B$7.88B$23.30B
Dividend YieldN/A3.89%2.47%3.78%
P/E Ratio-1.0642.1433.3329.57
Price / Sales0.235.188.123.18
Price / Cash1.0415.7621.0215.64
Price / Book1.375.794.804.06
Net Income-$534.51M-$19.09M$3.52B$1.08B
7 Day Performance3.23%-6.15%-4.56%-2.68%
1 Month Performance5.93%-4.37%-2.78%-0.79%
1 Year Performance15.85%-11.27%0.12%6.04%

Evolent Health Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
EVH
Evolent Health
2.4632 of 5 stars
$4.83
-1.5%
$6.04
+25.1%
+17.3%$545.74M$2.34BN/A4,200
SDGR
Schrodinger
1.8728 of 5 stars
$29.82
+3.6%
$26.67
-10.6%
+67.4%$1.93B$255.87MN/A850
CERT
Certara
1.8008 of 5 stars
$12.05
-1.1%
$9.92
-17.7%
+38.9%$1.63B$418.84MN/A1,576
TDOC
Teladoc Health
1.4539 of 5 stars
$8.80
-6.5%
$8.40
-4.5%
+27.3%$1.57B$2.53BN/A5,600
GDRX
GoodRx
3.6405 of 5 stars
$3.51
+0.6%
$4.23
+20.4%
+19.9%$1.22B$796.85M87.77697

Related Companies and Tools


This page (NYSE:EVH) was last updated on 11/16/2026 by MarketBeat.com Staff.
From Our Partners